UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014203
Receipt number R000016538
Scientific Title Randomized controlled study based on home blood pressure telemonitoring vs. conventional management in a remote island in Japan
Date of disclosure of the study information 2014/06/08
Last modified on 2014/06/07 23:28:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled study based on home blood pressure telemonitoring vs. conventional management in a remote island in Japan

Acronym

Randomized controlled study based on home blood pressure telemonitoring vs. conventional management in a remote island in Japan

Scientific Title

Randomized controlled study based on home blood pressure telemonitoring vs. conventional management in a remote island in Japan

Scientific Title:Acronym

Randomized controlled study based on home blood pressure telemonitoring vs. conventional management in a remote island in Japan

Region

Japan


Condition

Condition

hypertension

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We assessed whether a home BP telemonitoring system could improve BP control and overcome the problems of HBP monitoring in a remote location.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1) the changes in home morning and evening BP before and after treatment; 2) changes in the adherence to the HBP measurement protocol (calculated as the frequency of BP measurements in the latter half of the study (maximum frequency: 28) minus that in the first half (maximum frequency: 28); and 3) the visual analogue scale (VAS) scores as a measure of the motivation to perform HBP measurements (0=worst, 100=best).

Key secondary outcomes

We compared the changes in ankle brachial index (ABI), brachial ankle pulse wave velocity (baPWV), and urine albumin creatinine ratio (UACR) between the groups.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Patients used BP monitors with a telemonitoring system that stored and transmitted data to a secure website (HEM-7251G) .

Interventions/Control_2

Patients used conventional BP monitors (HEM-7080IC).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) diabetes mellitus or impaired glucose metabolism [during treatment or fasting blood glucose >110 mg/dL, 75gOGTT (2h) >140mg/dL]; 2) dyslipidemia (total cholesterol >240mg/dL or the use of lipid-lowering drugs); 3) hypertension (on medication or office SBP >140mmHg or office DBP >90mmHg; 4) current smoking (within 1 year); 5) kidney disease (albuminuria or creatinine >1.1 mg/dL; 6) atrial fibrillation; 7) metabolic syndrome; 8) chronic obstructive pulmonary disease; 9) sleep apnea syndrome.

Key exclusion criteria

1) current residence anywhere other than Niijima (or living off Niijima more than half of the year); 2) ischemic heart disease; 3) stroke (except asymptomatic and transient); 4) aortic dissection; 5) peripheral artery disease; 6) heart failure requiring hospitalization within the past 6 months; 7) hemodialysis; 8) inability to provide informed consent, self-measure BP, or walk; and 9) presence of serious diseases other than those described in the inclusion criteria.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kaihara Toshiki

Organization

Niijima-mura National Health Insurance Clinic

Division name

Division of internal Medicine

Zip code


Address

4-10-3 Honson, Niijima, Tokyo, Japan

TEL

04992-5-0083

Email

m03014tk@jichi.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Eguchi Kazuo

Organization

Department of Medicine, Jichi Medical University School of Medicine

Division name

Division of Cardiovascular Medicine

Zip code


Address

3311-1 Shimotsuke, Tochigi, Japan.

TEL

0285-58-7344

Homepage URL


Email

ke112@jichi.ac.jp


Sponsor or person

Institute

Jichi Medical University

Institute

Department

Personal name



Funding Source

Organization

Jichi Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

Clinical category #13-02

Org. issuing International ID_1

Jichi Medical University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 06 Month 07 Day

Date of IRB


Anticipated trial start date

2013 Year 08 Month 13 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 07 Day

Last modified on

2014 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016538


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name